• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dose-dependent pharmacokinetics of mezlocillin in rats.美洛西林在大鼠体内的剂量依赖性药代动力学
Antimicrob Agents Chemother. 1989 Jun;33(6):839-43. doi: 10.1128/AAC.33.6.839.
2
Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.剂量对美洛西林药代动力学及血清杀菌活性的影响。
Antimicrob Agents Chemother. 1987 Jun;31(6):895-8. doi: 10.1128/AAC.31.6.895.
3
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment.美洛西林在肾功能损害情况下的剂量依赖性药代动力学
Antimicrob Agents Chemother. 1982 Mar;21(3):428-35. doi: 10.1128/AAC.21.3.428.
4
Developmental pharmacokinetics of mezlocillin in 4 newborn infants.美洛西林在4名新生儿中的发育药代动力学。
Dev Pharmacol Ther. 1988;11(6):317-21. doi: 10.1159/000457710.
5
Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.合并用药对美洛西林和头孢噻肟在健康志愿者及肾衰竭患者中药代动力学的影响。
Clin Pharmacol Ther. 1989 May;45(5):527-34. doi: 10.1038/clpt.1989.68.
6
Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.不同程度肾功能患者单次静脉注射美洛西林后的药代动力学。
Antimicrob Agents Chemother. 1980 Apr;17(4):599-607. doi: 10.1128/AAC.17.4.599.
7
Investigation of mezlocillin disposition with a porcine model.用猪模型研究美洛西林的处置情况。
Biopharm Drug Dispos. 1989 Nov-Dec;10(6):563-72. doi: 10.1002/bdd.2510100605.
8
Developmental pharmacokinetics of mezlocillin in newborn infants.美洛西林在新生儿中的发育药代动力学。
J Pediatr. 1984 May;104(5):773-81. doi: 10.1016/s0022-3476(84)80966-x.
9
Nonlinear mezlocillin kinetics due to dose-dependent metabolism.由于剂量依赖性代谢导致的美洛西林非线性动力学。
Clin Pharmacol Ther. 1983 May;33(5):656-62. doi: 10.1038/clpt.1983.89.
10
Pharmacokinetics of two multiple-dose mezlocillin regimens.两种多剂量美洛西林给药方案的药代动力学
Antimicrob Agents Chemother. 1988 May;32(5):777-9. doi: 10.1128/AAC.32.5.777.

引用本文的文献

1
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.人体和临床前动物模型中未变化药物的尿排泄检查:提高人类代谢不良的预测性。
Pharm Res. 2021 Jul;38(7):1139-1156. doi: 10.1007/s11095-021-03076-y. Epub 2021 Jul 12.
2
Renal Clearable Luminescent Gold Nanoparticles: From the Bench to the Clinic.可清除肾脏的发光金纳米粒子:从实验室到临床。
Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4112-4128. doi: 10.1002/anie.201807847. Epub 2019 Jan 14.
3
Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.肾脏可清除金纳米颗粒的剂量依赖性和生物相容性:从小鼠到非人类灵长类动物。
Angew Chem Int Ed Engl. 2018 Jan 2;57(1):266-271. doi: 10.1002/anie.201710584. Epub 2017 Dec 5.
4
Inhibition of flucloxacillin tubular renal secretion by piperacillin.哌拉西林对氟氯西林肾小管分泌的抑制作用。
Br J Clin Pharmacol. 2008 Nov;66(5):648-59. doi: 10.1111/j.1365-2125.2008.03266.x.

本文引用的文献

1
LAGRAN program for area and moments in pharmacokinetic analysis.药代动力学分析中用于面积和矩的LAGRAN程序。
Comput Programs Biomed. 1983 Jun;16(3):203-16. doi: 10.1016/0010-468x(83)90082-x.
2
Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.β-内酰胺类抗生素基于生理的药代动力学模型I:大鼠体内的组织分布与消除
J Pharm Sci. 1983 Nov;72(11):1239-52. doi: 10.1002/jps.2600721103.
3
Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbits.甲氧西林在兔体内容量限制型组织分布的药代动力学
J Pharm Sci. 1984 Jul;73(7):867-73. doi: 10.1002/jps.2600730703.
4
Mezlocillin enteral absorption in rabbits.美洛西林在兔体内的肠道吸收情况。
Antimicrob Agents Chemother. 1981 Sep;20(3):418-9. doi: 10.1128/AAC.20.3.418.
5
Biliary elimination of mezlocillin: an experimental and clinical study.美洛西林经胆汁排泄的实验与临床研究。
Antimicrob Agents Chemother. 1980 Jul;18(1):69-76. doi: 10.1128/AAC.18.1.69.
6
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations.具有浓度依赖性蛋白结合特性的药物(头孢曲松)的分布容积术语。I. 理论考量。
Eur J Clin Pharmacol. 1983;25(3):399-405. doi: 10.1007/BF01037955.
7
Nonlinear mezlocillin kinetics due to dose-dependent metabolism.由于剂量依赖性代谢导致的美洛西林非线性动力学。
Clin Pharmacol Ther. 1983 May;33(5):656-62. doi: 10.1038/clpt.1983.89.
8
Dose-dependent pharmacokinetics of mezlocillin in relation to renal impairment.美洛西林在肾功能损害情况下的剂量依赖性药代动力学
Antimicrob Agents Chemother. 1982 Mar;21(3):428-35. doi: 10.1128/AAC.21.3.428.
9
Kinetics of mezlocillin in patients with biliary t-tube drainage.美洛西林在胆汁T管引流患者中的动力学
J Antimicrob Chemother. 1982 Jan;9 Suppl A:65-75. doi: 10.1093/jac/9.suppl_a.65.
10
Mechanisms of bile formation, hepatic uptake, and biliary excretion.胆汁形成、肝脏摄取及胆汁排泄的机制。
Pharmacol Rev. 1984 Mar;36(1):1-67.

美洛西林在大鼠体内的剂量依赖性药代动力学

Dose-dependent pharmacokinetics of mezlocillin in rats.

作者信息

Jungbluth G L, Jusko W J

机构信息

Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo 14260.

出版信息

Antimicrob Agents Chemother. 1989 Jun;33(6):839-43. doi: 10.1128/AAC.33.6.839.

DOI:10.1128/AAC.33.6.839
PMID:2764534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC284242/
Abstract

The pharmacokinetics of mezlocillin were examined in rats following bolus intravenous doses of 20 or 200 mg/kg. Mezlocillin exhibited bi- or triexponential disposition profiles, and the area under the concentration-time curve increased nonproportionally with dose similar to reported findings in humans. Apparent total, renal, and nonrenal clearances and the volume of distribution at steady-state all decreased by 45 to 50% with the higher dose, and the elimination half-life was longer (8 +/- 2 versus 15 +/- 3 min). Mezlocillin exhibits low saturable binding in rat serum, ranging from 20 to 40% bound. Pharmacokinetic parameters based on free drug demonstrated dose-dependent characteristics similar to those with total drug. Use of the volume of distribution from the low dose allowed calculation of the true mean residence time. The linear relationship between dose and mean residence time from free concentrations yielded pooled Michaelis-Menten parameters. These were used as initial estimates in the simultaneous nonlinear fitting of the low- and high-dose mean free concentrations to a three-compartment model with sequential distribution and Michaelis-Menten elimination to describe the nonlinearity of mezlocillin disposition further.

摘要

在大鼠静脉注射大剂量20或200mg/kg的美洛西林后,对其药代动力学进行了研究。美洛西林呈现出双指数或三指数处置曲线,浓度-时间曲线下面积随剂量增加而非比例增加,这与在人类中的报道结果相似。较高剂量时,表观总清除率、肾清除率和非肾清除率以及稳态分布容积均降低45%至50%,消除半衰期延长(8±2分钟对15±3分钟)。美洛西林在大鼠血清中的饱和结合率较低,结合率在20%至40%之间。基于游离药物的药代动力学参数显示出与总药物相似的剂量依赖性特征。使用低剂量的分布容积可计算出真正的平均驻留时间。剂量与游离浓度的平均驻留时间之间的线性关系产生了汇总的米氏参数。这些参数被用作初始估计值,用于将低剂量和高剂量的平均游离浓度同时非线性拟合到具有顺序分布和米氏消除的三室模型中,以进一步描述美洛西林处置的非线性。